BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu B, Sjölander A, Pedersen NL, Ludvigsson JF, Chen H, Fang F, Wirdefeldt K. Irritable bowel syndrome and Parkinson's disease risk: register-based studies. NPJ Parkinsons Dis 2021;7:5. [PMID: 33402695 DOI: 10.1038/s41531-020-00145-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zeng J, Wang X, Pan F, Mao Z. The relationship between Parkinson’s disease and gastrointestinal diseases. Front Aging Neurosci 2022;14:955919. [DOI: 10.3389/fnagi.2022.955919] [Reference Citation Analysis]
2 Tan AH, Lim SY, Lang AE. The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic. Nat Rev Neurol 2022. [PMID: 35750883 DOI: 10.1038/s41582-022-00681-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
3 Lu S, Jiang HY, Shi YD. Association between irritable bowel syndrome and Parkinson's disease: A systematic review and meta-analysis. Acta Neurol Scand 2022;145:442-8. [PMID: 34908158 DOI: 10.1111/ane.13570] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Padhi P, Worth C, Zenitsky G, Jin H, Sambamurti K, Anantharam V, Kanthasamy A, Kanthasamy AG. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders. Front Neurosci 2022;16:836605. [DOI: 10.3389/fnins.2022.836605] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
5 Hatano T, Oyama G, Shimo Y, Ogaki K, Nishikawa N, Fukae J, Nakamura R, Kurita N, Tsunemi T, Oji Y, Saiki S, Nishioka K, Takeshige-Amano H, Taniguchi D, Ogawa T, Kamo H, Eguchi H, Fuse A, Nakajima A, Kano M, Nakajima S, Yanagisawa N, Hattori N. Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson's disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD). BMJ Open 2022;12:e054129. [PMID: 35149566 DOI: 10.1136/bmjopen-2021-054129] [Reference Citation Analysis]
6 Zhang X, Svn Z, Liv M, Yang Y, Zeng R, Huang Q, Sun Q. Association Between Irritable Bowel Syndrome and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis. Front Neurol 2021;12:720958. [PMID: 34630293 DOI: 10.3389/fneur.2021.720958] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Aziz MNM, Kumar J, Muhammad Nawawi KN, Raja Ali RA, Mokhtar NM. Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain. Nutrients 2021;13:3061. [PMID: 34578939 DOI: 10.3390/nu13093061] [Cited by in F6Publishing: 4] [Reference Citation Analysis]